Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Devoogdt

Showing results (51-60 of 153) with videos related to

Pageof 16
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|October 11, 2019
Ultrasound Molecular Imaging of Atherosclerosis With Nanobodies: Translatable Microbubble Targeting Murine and Human VCAM (Vascular Cell Adhesion Molecule) 1Mukesh Punjabi, Lifen Xu, Amanda Ochoa-Espinosa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2013
Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancerCatarina Xavier, Ilse Vaneycken, Matthias D'huyvetter, et al.
International Journal of Molecular Sciences|January 8, 2020
Identification of Nanobodies against the Acute Myeloid Leukemia Marker CD33Ema Romão, Ahmet Krasniqi, Laila Maes, et al.
Pharmaceuticals (Basel, Switzerland)|July 2, 2021
Site-Specific Radiolabeling of a Human PD-L1 Nanobody via Maleimide-Cysteine ChemistryDora Mugoli Chigoho, Quentin Lecocq, Robin Maximilian Awad, et al.
Molecular Imaging and Biology|May 1, 2016
Non-Invasive Imaging of Amyloid Deposits in a Mouse Model of AGel Using <sup>99m</sup>Tc-Modified Nanobodies and SPECT/CTAdriaan Verhelle, Wouter Van Overbeke, Cindy Peleman, et al.
Diabetologia|December 25, 2019
A nanobody-based nuclear imaging tracer targeting dipeptidyl peptidase 6 to determine the mass of human beta cell grafts in miceStéphane Demine, Rita Garcia Ribeiro, Julien Thevenet, et al.
Biomaterials|February 3, 2017
Limiting the protein corona: A successful strategy for in vivo active targeting of anti-HER2 nanobody-functionalized nanostarsAntoine D'Hollander, Hilde Jans, Greetje Vande Velde, et al.
Vaccines|August 10, 2019
Single Domain Antibody-Mediated Blockade of Programmed Death-Ligand 1 on Dendritic Cells Enhances CD8 T-cell Activation and Cytokine ProductionKatrijn Broos, Quentin Lecocq, Brenda De Keersmaecker, et al.
Biomolecules|October 2, 2019
Noninvasive Imaging of the Immune Checkpoint LAG-3 Using Nanobodies, from Development to Pre-Clinical UseQuentin Lecocq, Katty Zeven, Yannick De Vlaeminck, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 2, 2014
Molecular imaging with macrophage CRIg-targeting nanobodies for early and preclinical diagnosis in a mouse model of rheumatoid arthritisFang Zheng, Stéphanie Put, Luc Bouwens, et al.
Pageof 16

Showing results (51-60 of 153) with videos related to

Sort By:
Pageof 16
Arteriosclerosis, Thrombosis, and Vascular Biology|October 11, 2019
Ultrasound Molecular Imaging of Atherosclerosis With Nanobodies: Translatable Microbubble Targeting Murine and Human VCAM (Vascular Cell Adhesion Molecule) 1Mukesh Punjabi, Lifen Xu, Amanda Ochoa-Espinosa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2013
Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancerCatarina Xavier, Ilse Vaneycken, Matthias D'huyvetter, et al.
International Journal of Molecular Sciences|January 8, 2020
Identification of Nanobodies against the Acute Myeloid Leukemia Marker CD33Ema Romão, Ahmet Krasniqi, Laila Maes, et al.
Pharmaceuticals (Basel, Switzerland)|July 2, 2021
Site-Specific Radiolabeling of a Human PD-L1 Nanobody via Maleimide-Cysteine ChemistryDora Mugoli Chigoho, Quentin Lecocq, Robin Maximilian Awad, et al.
Molecular Imaging and Biology|May 1, 2016
Non-Invasive Imaging of Amyloid Deposits in a Mouse Model of AGel Using <sup>99m</sup>Tc-Modified Nanobodies and SPECT/CTAdriaan Verhelle, Wouter Van Overbeke, Cindy Peleman, et al.
Diabetologia|December 25, 2019
A nanobody-based nuclear imaging tracer targeting dipeptidyl peptidase 6 to determine the mass of human beta cell grafts in miceStéphane Demine, Rita Garcia Ribeiro, Julien Thevenet, et al.
Biomaterials|February 3, 2017
Limiting the protein corona: A successful strategy for in vivo active targeting of anti-HER2 nanobody-functionalized nanostarsAntoine D'Hollander, Hilde Jans, Greetje Vande Velde, et al.
Vaccines|August 10, 2019
Single Domain Antibody-Mediated Blockade of Programmed Death-Ligand 1 on Dendritic Cells Enhances CD8 T-cell Activation and Cytokine ProductionKatrijn Broos, Quentin Lecocq, Brenda De Keersmaecker, et al.
Biomolecules|October 2, 2019
Noninvasive Imaging of the Immune Checkpoint LAG-3 Using Nanobodies, from Development to Pre-Clinical UseQuentin Lecocq, Katty Zeven, Yannick De Vlaeminck, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 2, 2014
Molecular imaging with macrophage CRIg-targeting nanobodies for early and preclinical diagnosis in a mouse model of rheumatoid arthritisFang Zheng, Stéphanie Put, Luc Bouwens, et al.
Pageof 16